Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | Curated by TDR Targets | References |
Homo sapiens | cholecystokinin B receptor | Starlite/ChEMBL | References |
Cavia porcellus | Cholecystokinin A receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.6672 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.8824 | 0.8824 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.147 | 0.0915 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0031 | 0.0255 | 0.0255 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0948 | 0.1661 |
Echinococcus multilocularis | thymidylate synthase | 0.013 | 0.4429 | 0.4871 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0031 | 0.0255 | 0.0255 |
Loa Loa (eye worm) | hypothetical protein | 0.0261 | 1 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.147 | 0.1419 |
Brugia malayi | thymidylate synthase | 0.013 | 0.4429 | 0.4429 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0062 | 0.1546 | 0.2317 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.013 | 0.4429 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.147 | 0.2912 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0053 | 0.1172 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.012 | 0.3999 | 0.3999 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.147 | 0.2912 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.1792 | 0.1792 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0053 | 0.1172 | 0.1071 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0053 | 0.1172 | 0.1172 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0031 | 0.0255 | 0.0255 |
Onchocerca volvulus | 0.013 | 0.4429 | 1 | |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 0.3999 | 0.3999 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0099 | 0.3117 | 0.3117 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.147 | 0.2204 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0068 | 0.1792 | 0.1792 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.147 | 0.1419 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0062 | 0.1546 | 0.1148 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.6672 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0233 | 0.8824 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.147 | 0.0915 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.013 | 0.4429 | 1 |
Brugia malayi | hypothetical protein | 0.0062 | 0.1546 | 0.1546 |
Echinococcus granulosus | thymidylate synthase | 0.013 | 0.4429 | 0.4871 |
Brugia malayi | dihydrofolate reductase family protein | 0.0053 | 0.1172 | 0.1172 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.013 | 0.4429 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.1792 | 0.3683 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.6672 | 1 |
Echinococcus granulosus | dihydrofolate reductase | 0.0053 | 0.1172 | 0.1071 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0048 | 0.0948 | 0.0948 |
Brugia malayi | Dihydrofolate reductase | 0.0053 | 0.1172 | 0.1172 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0062 | 0.1546 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0233 | 0.8824 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.147 | 0.0915 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.6672 | 1 |
Brugia malayi | hypothetical protein | 0.0233 | 0.8824 | 0.8824 |
Schistosoma mansoni | dihydrofolate reductase | 0.0053 | 0.1172 | 0.2198 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0255 | 0.0255 |
Brugia malayi | sulfakinin receptor protein | 0.0261 | 1 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.013 | 0.4429 | 0.4429 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0183 | 0.6672 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0099 | 0.3117 | 0.3117 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0099 | 0.3117 | 0.3117 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.006 | 0.147 | 0.2204 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.6672 | 1 |
Mycobacterium ulcerans | thymidylate synthase | 0.013 | 0.4429 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0048 | 0.0948 | 0.1661 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.3117 | 0.3117 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.147 | 0.0915 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 0.3999 | 0.3999 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 68 nM | Stimulation of amylase release in guinea pig pancreas | ChEMBL. | 1375964 |
IC50 (binding) | = 14 nm | Inhibition of specific binding of [125I]-BH-CCK-8 in guinea pig pancreas. | ChEMBL. | 1375964 |
IC50 (binding) | = 14 nm | Inhibition of specific binding of [125I]-BH-CCK-8 in guinea pig pancreas. | ChEMBL. | 1375964 |
IC50 (binding) | = 830 nm | Inhibition of specific binding of [125I]-BH-CCK-8 in guinea pig cortex | ChEMBL. | 1375964 |
IC50 (binding) | = 830 nm | Inhibition of specific binding of [125I]-BH-CCK-8 in guinea pig cortex | ChEMBL. | 1375964 |
Max (functional) | = 23 % | Hydrolysis of phosphoinositide (PI) relative to maximal response elicited by CCK-8 in guinea pig pancreas. | ChEMBL. | 1375964 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.